Radar Therapeutics Raises $13.4M in Seed Funding Led by NfX Bio to Develop Smart Programmable Medicines Using Molecular RNA Sensors
May 23, 2024•about 1 year ago
Amount Raised
$13.4 Million
Round Type
seed
Investors
BevcPear VcKd T VenturesBiovision VenturesEli Lilly And CompanyNf X Bio
Description
Radar Therapeutics, a biotech company, has completed an oversubscribed $13.4 million in seed financing led by NfX Bio. The funding will support the advancement of Radar’s internal programs, team expansion, and partnering.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech